RETA - Reata Pharmaceuticals Inc
IEX Last Trade
172.35
172.350 100.000%
Share volume: 0
Last Updated: Mon 25 Sep 2023 08:01:31 PM CEST
Pharmaceutical Preparation Manufacturing :
2.72%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
View ratios
Fiscal Date | 2023-03-31 | 2023-06-30 | |
---|---|---|---|
Fiscal Quarter | Q1 2023 | Q2 2023 | |
Report Date | 2023-05-10 | 2023-08-08 | |
Total revenue | 195.000 K | 22.746 M | |
Cost of revenue | 0.000 | 846.000 K | |
Gross profit | 195.000 K | 21.900 M | |
11,130.77% | |||
Operating expenses | 110.362 M | 102.810 M | |
Selling general and admin | 54.885 M | 45.690 M | |
Research and development | 55.477 M | 57.120 M | |
Total expenses | 110.650 M | 103.949 M | |
-6.06% | |||
Operating income | -110.455 M | -81.203 M | |
Ebit | -110.455 M | -81.203 M | |
Pretax income | -116.117 M | 192.998 M | |
-266.21% | |||
Income tax | 0.000 | 0.000 | |
Net income basic | -116.117 M | 192.998 M | |
266.21% | |||
Net income | -116.117 M | 192.998 M | |
266.21% |